Croda H1 Sales Rise 4.6% on Consumer Care Strength, Pretax Profit Misses Estimates

UK specialty chemicals firm Croda International reported a 4.6% rise in organic sales for the first half of 2026, buoyed by strong performance in its Consumer Care division. The company reaffirmed its full-year outlook, signaling confidence despite a mixed earnings report where pretax profit fell short of analyst expectations.

H1 Performance in Detail

Croda posted total sales of £880.50 million for the six-month period, slightly ahead of the £879.42 million consensus estimate from analysts, according to the report. The growth was primarily driven by its Consumer Care unit, with notable strength in the Beauty Actives and Home Care segments.

On the profit side, adjusted operating profit increased 6.7% organically to £155.80 million, marginally below an analyst estimate of £157 million. However, pretax profit of £107.40 million significantly missed the £147 million analyst forecast. The company's adjusted operating margin improved to 17.7%, which it attributed to benefits from a corporate transformation program, cost efficiencies, and positive price and mix changes.

Outlook and Shareholder Returns

Ad

Looking ahead, Croda maintained its guidance for the full year 2026. The company continues to expect key performance metrics to fall within established ranges:

• Group organic sales growth is forecast to be within its 3% to 6% target.
• The group's adjusted operating margin is anticipated to see a further increase.

Croda also cautioned that it expects a negative currency impact of approximately £4 million on full-year operating profit if exchange rates remain at June 2026 levels. In a sign of stability, the company held its interim dividend steady at £0.48 per share.